Manling Chen
Jiangsu Key Lab Of Cancer Biomarkers
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Outcomes With First-Line PD1 Inhibitors in Extranodal NK/T-Cell Lymphoma: A Comparative Analysis From a 755-Patient Multicenter Cohort.
Journal: American journal of hematology
Published: October 07, 2025
Novel loop structure of human IgG1 Fc fused CD38 targeted bispecific antibodies and their anti-tumor effect in acute myeloid leukemia.
Journal: Journal of translational medicine
Published: May 08, 2025
Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia.
Journal: British journal of haematology
Published: December 24, 2024
Construction and characterization of chimeric FcγR T cells for universal T cell therapy.
Journal: Experimental hematology & oncology
Published: July 21, 2024
Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia.
Journal: Experimental hematology & oncology
Published: June 26, 2024
Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells.
Journal: Cancer research
Published: January 12, 2024
Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.
Journal: Experimental hematology & oncology
Published: March 29, 2023
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.
Journal: Cancer communications (London, England)
Published: January 27, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026